Stay updated on Tizanidine in Cerebral Palsy Pediatric Clinical Trial
Sign up to get notified when there's something new on the Tizanidine in Cerebral Palsy Pediatric Clinical Trial page.

Latest updates to the Tizanidine in Cerebral Palsy Pediatric Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision label updates to v3.4.3, replacing v3.4.2. No study content appears to be altered.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe footer revision label was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page shows a minor version revision from v3.4.0 to v3.4.1 with no changes to core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedUI and labeling updates include a new 'Show glossary' option, standardization of labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new 'Revision: v3.4.0' entry; no substantive study content or results were changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page shows an updated revision label: v3.3.4 replacing the previous v3.3.3 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedLocations now lists Kentucky as a site under a generalized Locations section, replacing the former Kentucky Locations entry. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

Stay in the know with updates to Tizanidine in Cerebral Palsy Pediatric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tizanidine in Cerebral Palsy Pediatric Clinical Trial page.